File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/ph14050406
- Scopus: eid_2-s2.0-85105538636
- PMID: 33923054
- WOS: WOS:000654391800001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials
Title | COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials |
---|---|
Authors | |
Keywords | COVID-19 Vaccine Safety Efficacy Herd immunity |
Issue Date | 2021 |
Publisher | Molecular Diversity Preservation International. The Journal's web site is located at http://www.mdpi.org/pharmaceuticals/index.htm |
Citation | Pharmaceuticals, 2021, v. 14 n. 5, article no. 406 How to Cite? |
Abstract | Various strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations. |
Persistent Identifier | http://hdl.handle.net/10722/304545 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 0.845 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yan, ZP | - |
dc.contributor.author | Yang, M | - |
dc.contributor.author | Lai, CL | - |
dc.date.accessioned | 2021-09-23T09:01:34Z | - |
dc.date.available | 2021-09-23T09:01:34Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Pharmaceuticals, 2021, v. 14 n. 5, article no. 406 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | http://hdl.handle.net/10722/304545 | - |
dc.description.abstract | Various strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations. | - |
dc.language | eng | - |
dc.publisher | Molecular Diversity Preservation International. The Journal's web site is located at http://www.mdpi.org/pharmaceuticals/index.htm | - |
dc.relation.ispartof | Pharmaceuticals | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | COVID-19 | - |
dc.subject | Vaccine | - |
dc.subject | Safety | - |
dc.subject | Efficacy | - |
dc.subject | Herd immunity | - |
dc.title | COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials | - |
dc.type | Article | - |
dc.identifier.email | Lai, CL: hrmelcl@hkucc.hku.hk | - |
dc.identifier.authority | Lai, CL=rp00314 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/ph14050406 | - |
dc.identifier.pmid | 33923054 | - |
dc.identifier.pmcid | PMC8144958 | - |
dc.identifier.scopus | eid_2-s2.0-85105538636 | - |
dc.identifier.hkuros | 325484 | - |
dc.identifier.volume | 14 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | article no. 406 | - |
dc.identifier.epage | article no. 406 | - |
dc.identifier.isi | WOS:000654391800001 | - |
dc.publisher.place | Switzerland | - |